<DOC>
	<DOCNO>NCT00395811</DOCNO>
	<brief_summary>The purpose study determine whether intracoronary transfer autologous bone marrow cell induce angiogenesis , subsequently improve regional myocardial perfusion , finally result improve systolic diastolic leave ventricular function patient myocardial infarction . 50 patient stable left ventricle function - six month interval - receive two treatment bone marrow transplantation intracoronary vessel supply dysfunctional myocardial territory Coronary Artery Bypass Graft ( CABG ) .</brief_summary>
	<brief_title>Stem Cell Therapy Improve Myocardial Function Patients Undergoing Coronary Artery Bypass Grafting ( CABG )</brief_title>
	<detailed_description>This research study perform find information safety efficacy autologous bone marrow stem cell transplantation . In patient myocardial infarction , heart muscle pump well . Over period year , continue get bad patient dy heart failure . The researcher try find transplantation stem cell make change function area heart muscle . Patients 18 70 year age receive autologous bone marrow stem cell transplant Fuwai cardiovascular hospital may eligible study . Candidates must first transplant least 3 year enter current study . These patient receive autologous bone marrow cell transplantation intracoronary undergoing Coronary Artery Bypass Graft . The objective evaluation perform baseline 6 month follow-up . Heart function test may include follow : 1 . Electrocardiogram ( EKG ) evaluate electrical activity heart . Electrodes place chest transmit information heart machine . 2 . Echocardiogram ( Echo ) ultrasound test use sound wave create image heart examine function heart chamber valve . 3 . Gated acquisition scan nuclear medicine test use small amount radioactive chemical inject vein . A special scanner creates image heart examine beat motion muscle . 4 . MRI evaluate function heart chamber beat motion muscle .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<criteria>1 . Patients coronary disease undergo CABG . 2 . At least 3 month since last episode myocardial infarction 3 . Patients fulfil either follow criterion base extent CAD coronary angiography LVEF echocardiography . Reversible myocardial ischemia reveal SPECT . ejection fraction &gt; =40 % &lt; =50 % . Age &gt; =18 year &lt; =70 Patients give informed consent writing . 4 . Negative pregnancy test ( woman childbearing potential ) . Any one follow exclusion criterion sufficient disqualify patient study . 1 . Sustained ventricular tachycardia 24hour ECG . 2 . Chronic atrial fibrillation . 3 . Less 3 month since last episode cerebral infarction . 4 . Patients malignant tumor* . 5 . Patients chronic rheumatoid arthritis . 6 . Patients history severe allergic reaction . 7 . Patients hematological disease ( leukemia , myeloproliferative disease , myelodysplastic syndrome ) . 8 . Patients currently suffer history interstitial pneumonitis . 9 . Leukocytes less 4,000/µL exceed 10,000/µL . 10 . Platelets le 100,000/µL . 11 . Hemoglobin le 10 g/dL . 12 . AST ( GOT ) exceed 100 IU/L ALT ( GPT ) exceed 100 IU/L . 13 . Patients impossible perform cardiac MRI 14 . Pregnant nursing patient , may pregnant , plan become pregnant end study period . 15 . Any reason Clinical Supervisors Clinical Researchers may consider case unsuitable study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Myocardial Infarction</keyword>
	<keyword>stem cell therapy</keyword>
	<keyword>Coronary Artery Bypass Grafting</keyword>
</DOC>